Population-based rare variant detection via pooled exome or custom hybridization capture with or without individual indexing

  • Enrique Ramos1,

    Affiliated with

    • Benjamin T Levinson1,

      Affiliated with

      • Sara Chasnoff1,

        Affiliated with

        • Andrew Hughes1,

          Affiliated with

          • Andrew L Young1,

            Affiliated with

            • Katherine Thornton1,

              Affiliated with

              • Allie Li2,

                Affiliated with

                • Francesco LM Vallania1,

                  Affiliated with

                  • Michael Province1 and

                    Affiliated with

                    • Todd E Druley1, 3, 4Email author

                      Affiliated with

                      BMC Genomics201213:683

                      DOI: 10.1186/1471-2164-13-683

                      Received: 29 May 2012

                      Accepted: 23 November 2012

                      Published: 6 December 2012

                      Abstract

                      Background

                      Rare genetic variation in the human population is a major source of pathophysiological variability and has been implicated in a host of complex phenotypes and diseases. Finding disease-related genes harboring disparate functional rare variants requires sequencing of many individuals across many genomic regions and comparing against unaffected cohorts. However, despite persistent declines in sequencing costs, population-based rare variant detection across large genomic target regions remains cost prohibitive for most investigators. In addition, DNA samples are often precious and hybridization methods typically require large amounts of input DNA. Pooled sample DNA sequencing is a cost and time-efficient strategy for surveying populations of individuals for rare variants. We set out to 1) create a scalable, multiplexing method for custom capture with or without individual DNA indexing that was amenable to low amounts of input DNA and 2) expand the functionality of the SPLINTER algorithm for calling substitutions, insertions and deletions across either candidate genes or the entire exome by integrating the variant calling algorithm with the dynamic programming aligner, Novoalign.

                      Results

                      We report methodology for pooled hybridization capture with pre-enrichment, indexed multiplexing of up to 48 individuals or non-indexed pooled sequencing of up to 92 individuals with as little as 70 ng of DNA per person. Modified solid phase reversible immobilization bead purification strategies enable no sample transfers from sonication in 96-well plates through adapter ligation, resulting in 50% less library preparation reagent consumption. Custom Y-shaped adapters containing novel 7 base pair index sequences with a Hamming distance of ≥2 were directly ligated onto fragmented source DNA eliminating the need for PCR to incorporate indexes, and was followed by a custom blocking strategy using a single oligonucleotide regardless of index sequence. These results were obtained aligning raw reads against the entire genome using Novoalign followed by variant calling of non-indexed pools using SPLINTER or SAMtools for indexed samples. With these pipelines, we find sensitivity and specificity of 99.4% and 99.7% for pooled exome sequencing. Sensitivity, and to a lesser degree specificity, proved to be a function of coverage. For rare variants (≤2% minor allele frequency), we achieved sensitivity and specificity of ≥94.9% and ≥99.99% for custom capture of 2.5 Mb in multiplexed libraries of 22–48 individuals with only ≥5-fold coverage/chromosome, but these parameters improved to ≥98.7 and 100% with 20-fold coverage/chromosome.

                      Conclusions

                      This highly scalable methodology enables accurate rare variant detection, with or without individual DNA sample indexing, while reducing the amount of required source DNA and total costs through less hybridization reagent consumption, multi-sample sonication in a standard PCR plate, multiplexed pre-enrichment pooling with a single hybridization and lesser sequencing coverage required to obtain high sensitivity.

                      Keywords

                      Rare variants Genomics Exome Hybridization capture Multiplexed capture Indexed capture SPLINTER

                      Background

                      Evidence that rare genetic variation modulates common, complex phenotypes and diseases continues to mount [14], which has spurred efforts to study larger affected cohorts in order to have adequate statistical power for causative rare variant identification. However, despite the ever-declining costs of sequencing, recent efforts to sequence entire exomes [57] or use genome-wide array data to inform candidate gene selection [1] result in a huge expansion of the number of candidate genes to be surveyed. Yet, sequencing a large number of candidate loci in thousands of individuals remains largely cost prohibitive in terms of capture costs, sequencing costs and bioinformatic capability for the standard investigator. To address this limitation, we previously pioneered efforts in cost-effective, population-based rare variant detection using pooled DNA sequencing methods and the pooled sequencing analysis tools, SNPseeker and SPLINTER [8, 9]. While highly accurate and computationally efficient, these tools were designed for discreet target regions (e.g. <500 kb) and their aligners were inadequate for larger reference sequences.

                      In parallel, commercial capture-by-hybridization products have proven to be powerful tools for the custom enrichment of coding and/or other genomic regions of interest. These protocols are designed to hybridize complimentary oligonucleotide probes to the target regions of interest from a single DNA sample in a single incubation step. The efficacy of these methods to identify novel, deleterious monogenetic variants in Mendelian disorders has been reported in a variety of studies [47]. Newer products offer multiplexing of up to eight individuals in a single exome hybridization capture but require individual preparation of DNA libraries prior to hybridization, which increases DNA handling and reagent cost. Despite modest levels of available multiplexing, performing custom or exome hybridization capture on a large population of individuals followed by sequencing and data analysis remains a costly and time consuming proposition for most investigators.

                      To address these limitations, a variety of library preparation and multiplexing strategies, with and without individual indexing, have been put forth in the literature [1018]. There are a variety of things to consider when selecting a pooled hybridization method. We have considered these technical aspects when designing and comparing our method: is indexing used or anonymous pooling; how large of a pool can be created; if indexing is used, is possible cross-contamination of indexes reported and quantified; are duplicate reads accounted for in the data analysis; what percentage of raw data is on or near-target; how large of a capture is performed; how uniform is the resultant data for each individual within the pooled or multiplexed sample; and, finally, how accurate are the results. Cost is certainly an important parameter for consideration, but is difficult to quantify given the rapidly changing environment and access to certain platforms at different institutions. While not all of these studies report their findings in each of these categories, we find that our strategy compares favorably or surpasses reported findings in many instances (detailed further in the Discussion), yet remains cost-effective and practical for smaller labs requiring manual sample preparation.

                      Obtaining accurate results from pools without individual indexing, even modestly sized pools of 20–50 individuals, can be quite challenging [10, 11]. We have previously shown that the SPLINTER algorithm is highly sensitive for rare variant detection in pools of up to 500 individuals [9]. Previously, SPLINTER had only been used with PCR-amplified target sequences of modest total size. Here, we have expanded the capability of SPLINTER to larger target sequences acquired through solution hybridization capture without compromising its accuracy in a small pool of five exomes and in a larger pool of 92 individuals across 2.5 Mb. Our indexing strategy is compatible with low amounts of input DNA, less than 100 ng, which is often a limiting resource in large populations of DNA samples. This is primarily possible by eliminating all DNA sample transfers, including post-sonication, prior to hybridization and integrating a size-selection solid phase reversible immobilization (SPRI) bead cleanup strategy similar to that described by Fisher [19]. We employ a series of unique indexes that are effectively blocked using a single, novel blocking oligonucleotide incorporating deoxyinosine, rather than perfectly complimentary or degenerate sequences. This reduces cost and library complexity. We validated our methodology by comparing sequencing results to individual genotyping data and find an excellent concordance between pooled custom or exome hybridization capture results for common and rare variant detection. Overall, we believe this methodology provides a robust, scalable, accurate option for rare variant detection in complex phenotypes.

                      Results and discussion

                      Individual exome analysis

                      Initial reports of SureSelect [20] exome sequencing analysis used the program MAQ [21] to align short reads to the human genome [5, 7]. Subsequent steps involved calling substitutions with MAQ and then using Cross_match [22] for INDEL calling. However, we have previously demonstrated that MAQ is inadequate for the analysis of pooled DNA samples [9], and wanted to use the same alignment tool for both the individual and pooled sample to minimize differences in variant calling due to variable alignments. Our first experiment was to compare Affymetrix 6.0 genome-wide array (GWA), individual exome and pooled exome sequencing from the same five individuals (Additional file 1: Table S1, rows 1–5). Because the aligner included in the SPLINTER software package was not designed for large reference sequences, we elected to use Novoalign for sequence alignment, which performs gapped alignments enabling simultaneous calling of substitutions and INDELs. We then used SAMtools [23] for variant calling. We called all variants with ≥5-fold coverage/chromosome (≥10-fold/base position) to demonstrate a high degree of accuracy at low coverage thresholds, which facilitates costs savings through reduced sequencing. There was an average of 16,040 total variants called/person (range 15,824-16,186) and an average of 1,194 novel variants per person (range 1,073-1,284). Additional file 1: Table S2 lists sequencing metrics for each individual.

                      To validate our individual and pooled sequencing results, we compared common positions between the exome sequencing and the GWA, as well as individual genotyping by Sequenom MassArray [24] for 127 positions, including six novel variants, not on the GWA and falling within genes of potential biological relevance for the phenotype under investigation within these individuals. Additional file 1: Figure S2A shows a highly reproducible average sensitivity across all five individuals of 96.9% (range 96.3 – 97.3%). Similarly, Additional file 1: Figure S2B shows a highly reproducible average specificity of 99.8% (range 99.7 – 99.8). Additional file 1: Table S3 lists results from individual genotyping compared to individual and pooled exome sequencing. We found that 95.3% were identical, including all novel variants, between individual exome sequence analysis and genotyping. These data demonstrate that our bioinformatic pipeline is not only computationally efficient, but also accurate even with as little as 5-fold coverage/chromosome.

                      Pooled exome analysis

                      After establishing the accuracy of the single exome analysis, we focused on adapting the Novoalign alignment pipeline for integration with SPLINTER. To test this, we prepared a pool of normalized DNA from the same five individuals previously analyzed separately (pool size of 10 alleles). Systematic sequencing platform errors were modeled and subtracted from raw data as previously published [9], Additional file 1: Figure S1]. Additional file 1: Figure S2A shows that our pooled sequencing sensitivity slightly outperformed our individual exome sensitivity, demonstrating an accuracy of 99.4%. This improvement is likely due to the fact that we only considered called variants from pooled sequencing with ≥20-fold coverage based on prior results [9], supporting the idea that we could improve our individual exome variant calling sensitivity by restricting to positions with higher coverage thresholds. Figure 1 shows the correlation for substitution minor allele frequencies (MAF) between the individual and pooled sequencing to be R 2 = 0.97, suggesting uniform capture and representation of the minor alleles in the pooled sample. Positions deviating from the idealized correlation are shown to be deficient in sequencing coverage in either the single or pooled sequencing (Additional file 1: Figure S3). Additional file 1: Figure S2B shows the specificity of the pooled hybridization capture to be 99.7%. Considering the non-array positions individually genotyped by Sequenom (Additional file 1: Table S3), we find a correlation of R 2 = 0.81 between SPLINTER and either SAMtools or Sequenom. The lower correlation is due to seven no-calls by SPLINTER. For SPLINTER to call a variant, the complimentary base change must be noted on each strand to a degree that passes the defined P-value cutoff. In these cases, one strand failed to achieve adequate sequencing that surpasses the P-value threshold, thus leaving these positions uncalled.
                      http://static-content.springer.com/image/art%3A10.1186%2F1471-2164-13-683/MediaObjects/12864_2012_4539_Fig1_HTML.jpg
                      Figure 1

                      Allele frequency by individual versus pooled exome sequencing. Correlation plot comparing a total of 2,937 positions found in the Agilent SureSelect hybridization exome capture and Affymetrix 6.0 array between individual versus pooled exomes. Difference in size between the spheres represents the relative number of variant positions with the same minor allele frequency.

                      Pooled custom hybridization capture

                      For this experiment, we analyzed non-indexed pooled sequencing results of 464 candidate genes (Additional file 1: Table S4) from 92 individuals enrolled in the Long Life Family Study (LLFS, see Methods for details). Each individual had Illumina HumanOmni 2.5-8 Beadchip GWA data available for comparison. Using filtering criteria listed in Methods under “Pooled sequencing analysis of 92 individuals at 464 genes”, we identified 875 substitutions for comparison. Of these, 499 were called polymorphic at some frequency by SPLINTER or the GWA, yielding a concordance of R 2 = 0.984 (Figure 2). There were 116 rare substitutions within this dataset (MAF <5%) and 104 (89.7%) were called within 1% of the array-based MAF by SPLINTER, 2 were not called and the remaining 10 were called within 2% of the array-based MAF. At least some of the discrepancies were likely due to GWA errors. When considering only the 396 substitutions called homozygous wild type by GWA, we find a specificity of 94.9%. However, if we exclude positions from consideration that have an INDEL within 15 bp called by sequencing in at least one individual, 25 positions are excluded and our specificity improves to 97.8%. This suggests false negative array errors due to nearby INDELs that adversely affect probe binding.
                      http://static-content.springer.com/image/art%3A10.1186%2F1471-2164-13-683/MediaObjects/12864_2012_4539_Fig2_HTML.jpg
                      Figure 2

                      Pooled capture SNV minor allele frequency correlation. Correlation plot comparing a total of 499 positions that overlapped between the custom hybridization targeted regions and the Illumina Omni-2.5-8 genome wide SNV array with at least one variant called by the array or pooled analysis. Of these 499 positions, 477 (95.6%) had at least one variant allele call by both SPLINTER and the array, 20 were called as SNVs by SPLINTER but not by the array, and 2 were called as SNVs by the array but not by SPLINTER.

                      For INDEL analysis in this experiment, we aggregated the INDEL calls from the individual sequencing of all 92 individuals and compared against SPLINTER’s calls. When restricting our analysis to 1 bp INDELs, SPLINTER identified 90% (99 of 110) with a concordance of R 2 = 0.73 (Additional file 1: Figure S4). For rare INDEL calling (MAF <5%), SPLINTER detected 83.3% (45 of 54). While these results are good overall, the dropoff in concordance from substitution detection to that of INDELs further highlights the difficulty of accurate INDEL detection.

                      Thus, we have expanded the prior capability of the SPLINTER algorithm for use with any size target sequence. SPLINTER was previously shown to outperform other algorithms, such as CRISP [18], for rare variant and INDEL detection in anonymous pools of up to 500 individuals [9], but the aligner was not efficient for survey of large reference sequences. Recent reports of anonymous pooling from smaller pools of 2–50 individuals [10, 11, 18] use hybridization capture on smaller capture targets (up to 1.6 Mb). Both studies removed duplicate reads prior to alignment and report 48-55% of data on target (compared to our 42-47%). However, Harakalova failed to validate any called variant predicted at less than 25% MAF in pools of 20 [11]. Day-Williams found that solution hybridization capture outperformed PCR or array-based hybridization methods and report a sensitivity and specificity of 98.2% and 97.0% for a smaller pool of 20 individuals using MAQ v0.1.7 for alignment and Syzygy for SNV calling with no analysis of INDELs. Bansal and colleagues surveyed 594 kb in pools of 20 and report a sensitivity of 93% at 30-fold coverage for substitutions and a positive predictive value of 87% for INDELs compared to a false positive rate of 0.9%. In comparison, we find a sensitivity of >96% at 20-fold coverage in a pool of four captures of 22–24 each.

                      Indexed custom hybridization capture

                      While pooling samples without indexing is cost-effective for surveying sequence variation between populations, it’s obviously advantageous to directly link a called variant to a particular individual within the multiplex. A variety of studies have introduced barcodes or indexing into multiplexes ranging in size from 5–96 individuals for target sizes of 0.14-3.3 Mb [1218]. These reports start with anywhere from 0.2-3 μg of DNA per individual. Rohland and Reich created libraries with as little as 200 ng of DNA/person but report 50% sample loss from their blunt end adapter ligation strategy and therefore recommend using ≥500 ng of DNA/pp [16]. We have also adopted a blunt-end adapter ligation strategy incorporating Y-shaped adapters and have not seen significant sample loss, which has enabled comparable outcomes from libraries starting with 70 ng/pp up through 350 ng/pp. In addition, we present a novel, simplified adapter blocking strategy using deoxyinosines along with a custom set of 96 indexes (Additional file 1: Table S5).

                      In this experiment, we analyzed sequencing data from the same 464 candidate genes (Additional file 1: Table S4) in 280 LLFS individuals and incorporated individual DNA indexing prior to pre-hybridization multiplexing. To test pre-enrichment multiplexing of various sizes, we created nine separate multiplexes of 22 (n = 1), 23 (n = 2), 24 (n = 1), 30 (n = 2), 32 (n = 1) and 48 (n = 2) and using 70–350 ng DNA/pp. Additional file 1: Table S1 lists how the multiplexes were then combined for three separate lanes of HiSeq 2000 sequencing with 92–96 individuals in each lane. We first studied the single lane of 92 individuals from four multiplexes of 22–24 individuals each (rows 7–10), and found that >96% of raw data contained an identifiable index and that >97% of the individuals (2 samples failed) were within a 2.3-fold difference in raw read counts (Additional file 1: Figure S5). Also, individuals did not cluster predominantly within distinct captures (compare the distribution of symbols within each dataset in Additional file 1: Figure S5), suggesting that the library preparation and hybridization was highly uniform and did not introduce bias in the sequencing output. After excluding the two failed samples, aligning unique reads and removing PCR duplicates, 81.9% (±1.8) of total reads per person were aligned in a trend that closely followed the number of raw reads per sample (Additional file 1: Figure S5, cyan symbols). We observed 13.4% (±1.9) PCR duplication (Additional file 1: Figure S6, red symbols). After removing these duplicates, 41.8% (±1.1) of the aligned bases were on or within 250 bp (“on or near target”) of our targeted intervals and 33.4% (±0.9) were directly on targeted regions (Additional file 1: Figure S6, blue and green symbols respectively), demonstrating that the percent duplication and capture efficiency were uniform between all samples and the four independent multiplexes. In addition, we demonstrated that our candidate regions were enriched uniformly across the four multiplexes, showing an average pairwise R 2 = 0.936 (Additional file 1: Figure S7). Thus, our method performs uniformly with respect to both aggregate metrics of an entire capture as well as bait-to-bait capture efficiency.

                      As discussed by Rohland and Reich [16], many capture methodology papers do not report the number of duplicate reads observed nor specify if duplicate reads are removed prior to alignment [1214, 17, 18] and only report the percentage of their reads that align on or near target, not directly on target, which may inflate the amount of usable data. Rohland reports 24% duplicate reads, and we find a comparable percentage of 14-32% duplicate reads in our various multiplexes. While our percentage of on/near target reads is comparable to the 18-55% on/near target reads reported [1215, 17, 18], these numbers may be inflated by the inclusion of duplicates. In our initial multiplexed samples, we find an average of 81.9% of our reads remaining after aligning and removing duplicates, and an average of 33.4% of the remaining bases aligning to our targeted regions. Thus, approximately 27.4% of our raw data aligns to our targeted regions in our processed aligned files, yielding an average fold enrichment of 413 (±10.8). Overall, we achieved an average mean target coverage of (30.43 ± 4.54) when targeting 2.5 Mb with one lane of sequencing and yielding ~130 million reads. While within range of prior data, we expected to obtain a higher on-target percentage. The most obvious reason for this seemed to be our modified adapter blocking strategy allowing daisy-chaining, but could also be due to limitations in oligonucleotide hybridization efficiency either through non-specific hybridization to non-target genomic regions or because early versions of Agilent SureSelect custom captures did not incorporate “bait boosting”, which calibrates the relative amount of bait sequences to normalize the expected binding efficiency to each target. While we could not alter the baits within our capture set, we did improve our blocking strategy by incorporating 1 μL of the Illumina PE 1.0 post-hybridization PCR primer sequence (Additional file 1: Table S5, the longer oligonucleotide listed under “Post-Hybridization PCR primers”). This step improved our average on-target percentage to >70% over our next 18 multiplexed libraries (data not shown), which is comparable to the 79% on/near target reads using a shortened adapter strategy published by Rohland [16].

                      Analysis of the data from the lane with two 48-individual multiplexes (Additional file 1: Table S1, rows 14–15) found very similar results for what we observed from multiplexes of 22–24 with respect to the percent of raw reads with an identifiable index, the percentage of aligned data per person, and the uniformity of data between individuals and between captures (Additional file 1: Figure S5, black symbols). This experiment showed a higher fold enrichment of 466 (±17.2) with 31.6% (±1.5) PCR duplication (Additional file 1: Figure S8, red symbols). After removing these duplicates, our on/near-target percentage improved to 47.2% (±1.4) and 37.7% (±1.39) were directly on targeted regions (Additional file 1: Figure S8, blue and green symbols respectively). We attribute the higher PCR duplication rate in the multiplexes of 48 individuals over the multiplex of 22–24 individuals to the fact that we have reduced the library complexity through two mechanisms. First, we only pooled 35 ng of pre-hybridization capture DNA per individual instead of 50 ng as done with the multiplexes of 22–24, which would result in a lesser amount of unique DNA fragments available for the post-adapter ligation enrichment PCR. Second, with 48 individuals pooled for a single bait set, there is approximately half as much DNA selected per individual as for captures with 22–24 individuals pooled. Thus, with similar overall read counts per person, we would expect to see a greater number of PCR duplicates as a result.

                      As there were over 4,000 overlapping positions between the Omni 2.5-8 array and our targeted regions, we used these validated positions to accurately assess our sensitivity and specificity at various coverage thresholds. Table 1 shows sensitivity, specificity, and coverage metrics for the custom multiplexes at different MAF thresholds. As expected, sensitivity is a function of coverage, starting at >95% with >3-fold coverage for common variants and improving to 100% with >20-fold coverage for rare variants (Table 1 and Figure 3). Specificity was consistently ≥99.8% and hardly impacted by coverage regardless of MAF, confirming that our method does not systematically introduce false positives (Table 1 and Figure 4). For rare variants with ≤2% MAF in this experiment, we find a sensitivity of 92.9-99.6% and 94.7-100% with coverage ranging from ≥3-20-fold for variants with 2% MAF and 0.5% MAF, respectively (Table 1). Specificity was ≥99.99% at all coverage levels for either MAF. These results indicate that allele dropout is not occurring with our method.
                      Table 1

                      Comparing sensitivity and specificity to coverage achieved for three sets of multiplexes

                       

                      All allele frequencies

                      ≤5% MAF

                      2% MAF(4 alleles in pool)

                      0.5% MAF(1 allele in pool)

                      Size Multiplex

                      Coverage

                      Percent of Bases, average (SD)

                      Homozygous wild type sites

                      Heterozygous sites

                      Homozygous variant sites

                      Sensitivity average (SD)

                      Specificity, average (SD)

                      Homozygous wild-type sites

                      Heterozygous sites

                      Homozygous variant sites

                      Sensitivity (avg)

                      Specificity (avg)

                      Heterozygous sites

                      Sensitivity (avg)

                      Specificity (avg)

                      Heterozygous sites

                      Sensitivity (avg)

                      Specificity (avg)

                      22-24

                      ≥3

                      84.4(1.29)

                      229483

                      39100

                      24855

                      95.02(1.42)

                      99.82(0.14)

                      172205

                      2057

                      20

                      92.49

                      99.98

                      656

                      91.6

                      99.98

                      127

                      88.3

                      99.99

                       

                      ≥5

                      84.6(1.75)

                      221031

                      37332

                      23810

                      96.75(1.23)

                      99.82(0.14)

                      166050

                      1961

                      19

                      95.30

                      99.98

                      624

                      94.9

                      99.99

                      119

                      90.2

                      99.99

                       

                      ≥10

                      75.0(2.65)

                      201268

                      33626

                      21451

                      98.22(0.98)

                      99.86(0.13)

                      151395

                      1768

                      17

                      97.42

                      99.98

                      563

                      96.6

                      99.99

                      111

                      93.8

                      100

                       

                      ≥15

                      67.1(3.57)

                      182332

                      30279

                      19510

                      98.60(0.93)

                      99.88(0.12)

                      137327

                      1579

                      17

                      98.50

                      99.98

                      507

                      98.0

                      99.99

                      100

                      96.0

                      100

                       

                      ≥20

                      59.8(4.51)

                      163986

                      27202

                      17643

                      98.94(0.83)

                      99.89(0.12)

                      123572

                      1418

                      14

                      98.81

                      99.98

                      460

                      98.7

                      100

                      90

                      95.6

                      100

                      48

                      ≥3

                      89.0(2.30)

                      239300

                      39218

                      26310

                      95.80(1.42)

                      99.90(0.08)

                      187077

                      2109

                      25

                      92.97

                      99.97

                      651

                      92.9

                      99.99

                      131

                      94.7

                      100

                       

                      ≥5

                      84.1(3.14)

                      230685

                      37434

                      25232

                      96.43(0.95)

                      99.91(0.08)

                      179900

                      1997

                      25

                      95.95

                      99.97

                      619

                      95.8

                      99.99

                      125

                      96.8

                      100

                       

                      ≥10

                      74.8(4.54)

                      209960

                      33448

                      22739

                      98.96(0.51)

                      99.94(0.07)

                      163128

                      1805

                      22

                      98.30

                      99.97

                      566

                      98.4

                      99.99

                      111

                      100

                      100

                       

                      ≥15

                      67.1(5.79)

                      190652

                      30010

                      20491

                      99.33(0.42)

                      99.95(0.07)

                      147843

                      1630

                      19

                      98.85

                      99.97

                      517

                      99.0

                      99.99

                      100

                      100

                      100

                       

                      ≥20

                      60.3(6.98)

                      172373

                      26937

                      18505

                      99.60(0.37)

                      99.96(0.06)

                      133259

                      1449

                      18

                      99.05

                      99.97

                      467

                      99.6

                      100

                      88

                      100

                      100

                      30-32

                      ≥3

                      89.2(2.55)

                      245952

                      40732

                      26487

                      96.52(1.08)

                      99.97(0.03)

                      184498

                      1903

                      16

                      93.54

                      99.97

                      664

                      95.6

                      99.98

                      102

                      97.1

                      99.99

                       

                      ≥5

                      84.4(3.49)

                      235796

                      38696

                      25251

                      98.23(0.69)

                      99.97(0.03)

                      177279

                      1809

                      16

                      96.33

                      99.97

                      644

                      97.1

                      99.99

                      102

                      97.1

                      100

                       

                      ≥10

                      74.8(5.35)

                      212716

                      34440

                      22505

                      99.43(0.40)

                      99.97(0.03)

                      160352

                      1600

                      14

                      98.88

                      99.97

                      567

                      99.1

                      99.99

                      99

                      96.8

                      100

                       

                      ≥15

                      66.8(7.25)

                      192642

                      30957

                      20272

                      99.80(0.19)

                      99.98(0.03)

                      145504

                      1403

                      12

                      99.58

                      99.98

                      497

                      99.4

                      100

                      82

                      97.6

                      100

                       

                      ≥20

                      59.5(9.08)

                      173212

                      27775

                      18237

                      99.90(0.15)

                      99.98(0.03)

                      130959

                      1260

                      10

                      99.76

                      99.98

                      448

                      99.6

                      100

                      72

                      98.8

                      100

                      The percent of bases in the targeted intervals that reached the specified coverage threshold is listed. Homozygous wild type, heterozygous, and homozygous variant sites surveyed indicates the number of each of those positions as seen by the Illumina Omni 2.5-8 array that were used to determine sensitivity and specificity. Sensitivity is the percentage of heterozygous and homozygous variant sites correctly called heterozygous and homozygous variant, respectively. Specificity is the percentage of homozygous wild type sites called as homozygous wild type. For “All allele frequencies” these values were averaged among all non-excluded samples. For ≤5%, 2% and 0.5% minor allele frequencies, these values were determined from the cumulative metrics of all non-excluded samples at sites with 9 or fewer, 4 or fewer, or 1 variant allele in the entire pool, respectively.

                      http://static-content.springer.com/image/art%3A10.1186%2F1471-2164-13-683/MediaObjects/12864_2012_4539_Fig3_HTML.jpg
                      Figure 3

                      Sensitivity as a function of total paired-end read counts at different coverage thresholds for all variants in the sets of 48 multiplexed samples. This graph shows how the sensitivity increases per the number of reads for a given sample with a shallow increase at 5-fold coverage after a sample reaches 1.8 million reads. Sensitivity is defined as the percentage of heterozygous or homozygous variant genotypes as seen by the array called correctly as heterozygous or homozygous by sequencing. Red symbols: ≥3x coverage. Green symbols: ≥5x coverage. Blue symbols: ≥10x coverage. Brown symbols: ≥15x coverage. Black symbols: ≥20x coverage. Trend lines were generated using the “lowess” function in R with default parameters. The sensitivity appears to plateau at around 1.8 million reads, which is prior to excluding duplicate reads and reads that align off-target. PE = paired-end.

                      http://static-content.springer.com/image/art%3A10.1186%2F1471-2164-13-683/MediaObjects/12864_2012_4539_Fig4_HTML.jpg
                      Figure 4

                      Specificity as a function of total paired-end read counts at different coverage thresholds for the sets of 48 multiplexed samples. Coverage has little impact on specificity, which starts at ≥99.8% for most individuals with >1.25 million reads. Specificity is defined as the percentage of homozygous wild type genotypes as seen by the array called correctly as homozygous wild type by sequencing. Red symbols: ≥3x coverage. Green symbols: ≥5x coverage. Blue symbols: ≥10x coverage. Brown symbols: ≥15x coverage. Black symbols: ≥20x coverage. Trend lines were generated using the “lowess” function in R with default parameters. The dip in specificity at around 2.25 million reads is likely due to noise as a single extra false positive can cause the observed shift downward. PE = paired-end.

                      Additional file 1: Figure S9 compares sequencing coverage from a single individual for all common GWA positions against all bases in our 2.5 Mb capture with 1.4 M paired-end reads. Once a base position surpasses 3-fold coverage, the representation of GWA positions versus any base position with similar coverage is approximately equivalent (as are the mean and median values). These results support using high-density GWA positions for validation of sequencing results and extrapolating to the entire dataset. We then analyzed our non-array variant calls from our multiplexes of 48 (Table 1, rows 14–15) for accuracy. Any variant found in the Exome Variant Server and not considered a likely false positive by their Support Vector Machine (SVM) [25] was considered. Of the 10,854 non-SVM, non-GWA variant calls made, 9,622 are in dbSNP135 (88.65%). This degree of overlap would not be observed if variants were being called by random chance.

                      We have also surveyed all variation in our multiplexes of 22–24 individuals (Additional file 1: Table S1, rows 7–10) to calculate the Ti:Tv ratio according to the work of DePristo [26] (for details see Additional file 1: Results under “Transition : Transversion (Ti/Tv) ratio analysis”). We find additional support that we are calling variants as expected, particularly those positions with ≥15-fold coverage.

                      Often, DNA samples are a precious resource, with very little material in which to conduct large scale genomic surveys. We have been able to use relatively little source DNA per person by eliminating all sample transfers prior to pooling, which is enabled by having SPRI beads present in solution from the beginning of the protocol. These beads can stay in place and do not appear to alter the quality of the library creation reactions. Our strategy is modified from prior reports by Rohland [16] and Fisher [19]. Many investigators do not have access to full automation of the hybridization capture library creation process. Fisher introduced exclusive bead cleanup for use with fully automated single exome library creation, without multiplexing. While results were highly uniform when employed with full automation, there was a large dropoff in the percentage and uniformity of captured bases when bead cleanup was performed manually [see ref. [19], Additional File 10. Rohland performed sonication in a 96-well PCR plate without beads present in solution (unlike us) and also optimized their bead cleanup for automation. However, as mentioned above, they report a loss of 50% of source DNA after adapter ligation. We have exclusively performed manual library preparations with multichannel pipettors and observe excellent recovery of source DNA, which is a cost effective and accurate alternative that is accessible to any lab.

                      We investigated whether issues such as bait GC content or strand bias adversely impacted our results. We observed a large dropoff in sequencing coverage with baits that were high in GC content and targets <180 bp (discussed further in Additional file 1: Figures S10a and 10b), and performed an analysis to centeracterize whether strand bias impacted our variant calling (Additional file 1: Figure S11). From these results, we believe that GC bias in hybridization efficiency can be mitigated through “bait boosting” (or designing baits with no more than 35% GC content) and strand bias did not adversely effected our results.

                      However, one serious potential drawback in integrating large scale indexing would be data contamination due to index switching, or the transfer of an index from one individual to the sequencing read of another individual. Unexpectedly, the multiplexes of 22–24 and 48 demonstrated superior specificity for rare variants rather than common variants, which seems counterintuitive, but is a consistent finding at all coverage thresholds (Table 1). To explore this result further, we considered the validated positions binned by the number of variant alleles at each position called by array genotyping in the entire pool of 96 captured in two multiplexes of 48 (Additional file: 1 Table S6). The percentage of reads with variant alleles in individuals who were homozygous wild type at these positions increases as a function of the frequency of the variant allele in each bin. This indicated to us that there was up to 9% of reads with an inappropriate index in our samples. We use a large excess of adapters to drive ligation of every possible template strand. We surmised that a large percentage of our misattributed indexes were due to an excess of unligated adapters present in the PCR enrichment, as shown by the bimodal peaks in the green tracing on Additional file 1: Figure S12 and schematically diagrammed in Additional file 1: Figure S13. We tested this by adding an additional bead purification step to remove to remove unligated adapters from our multiplexes of 30–32 individuals (Table 1, rows 11–13). We further analyzed variants with a MAF of ~50% (Additional file 1: Table S6) and see an equivalent specificity for common and rare variants with the inclusion of this step (Table 1, rows 11–13). In addition, the lesser degree of misattributed indexes in the multiplexes of 30–32 improves sensitivity for common and rare variants compared to the prior multiplexes. Our results suggest that index switching is a random and stochastic process resulting in approximately 3.4% of reads in the entire pool attributed to an incorrect index. We propose a mechanism for index switching in Additional file 1: Figure S13. None of the previously mentioned reports on multiplexed hybridization capture discuss this [1218] which may further skew their findings, but one possible source of this observation is covered in detail by Kircher and colleagues [27] as “jumping PCR”. Kircher reports that over 0.7% of misattributed indexes are expected when pooling samples prior to PCR for multiplexed capture. If we subtract this source of error from our result, we are left with 2.64% of reads with an incorrect index (a 3.5-fold improvement from initial experiments). The source of this is unclear, but may be caused by further residual unligated indexes in our sample prior to PCR enrichment, a different rate of “jumping PCR” due to innate differences in polymerases used (Amplitaq Gold by Kircher vs. the TruSeq kit reagents), or perhaps erroneous array calls. Thus, while our percentage of incorrectly indexed reads was not as low as reported by the double indexing strategy of Kircher [27], the amount we did have did not appear to impact our accuracy for common or rare variant detection.

                      Conclusions

                      The genomic analysis of rare variants in complex disease will continue to drive pathophysiological research and clinical questions. Sequencing many individuals at any number of candidate loci is required to obtain the statistical power necessary for detecting disease-related, rare functional genetic variants associated with complex phenotypes. As sequencing capacity continues to increase, the need for additional multiplexing is required to maximize the efficiency of the sequencing output. Pooling will also enable sequencing to move more readily into the diagnostic arena as a more cost effective method for screening multiple genes for rare functional variation. We report a cost-effective and fully scalable, pre-hybridization multiplexed in-solution capture method, amenable to <100 ng of input DNA per person due to removal of sample transfers during library preparation enabled by the constant presence of SPRI beads and resulting in a 50% reduction in the volume of library preparation reagent necessary. Sequencing analysis was performed by bioinformatic pipelines aligning raw data with Novoalign and calling variants from anonymous pools using SPLINTER or indexed samples using SAMtools. Both pipelines showed consistent, coverage-dependent high sensitivity ranging from 95-99% for substitutions with a dropoff in concordance for detecting INDELs. For rare variants (MAF <2%), we achieved a sensitivity and specificity of 99.4% and 99.7% for pooled exome analysis and ≥96.6% and ≥99.99%, respectively, for custom capture libraries of 22–48 individuals. While within the range of published reports, we found our on-target percentage to generally be in the 40-50% range, but has improved with the addition of another post-enrichment PCR primer to act as an additional blocker. Our blocking strategy utilizes deoxyinosines to span the novel 7 bp indexes rather than degenerate nucleotides to reduce the complexity of the DNA mixture. In our system, we found that optimal hybridization and sequencing representation occurred with baits having 25-35% GC content and targets of >240 bp. We also found no negative impact due to strand bias. However, one serious drawback to larger multiplexing of indexed samples is index switching leading to the attribution of variants to the incorrect individual. We have quantified the prevalence of this phenomenon and shown it to occur most frequently at wild-type or common variant positions simply due to the abundance of those reads in the sample. By incorporating an additional purification step during library preparation to remove excess unligated adapters, this effect can be mitigated. In sum, cost savings can be realized through the use of less pre-enrichment library preparation reagents, use of more standard plasticware for sonication, capturing up to 48 individuals with a single hybridization, multiplexing multiple libraries for sequencing, and the ability to call rare variants accurately with as little as 5-fold sequencing as a lower threshold (albeit sensitivity improves with higher coverage). While there are a variety of reports describing pooled sequencing or multiplexed solution hybridization capture [1018], our method offers a highly uniform, reproducible workflow for smaller labs that may not have access to high-throughput robotics but still wish to quantify rare variation within specific populations.

                      Methods

                      Individual and pooled exome sequencing library preparation

                      DNA was isolated from buccal swabs collected from a nuclear family of five Caucasian individuals (four females and one male) in accordance with Washington University Human Research Protection Office protocol #10-0340. DNA was prepared for sequencing according to the protocol included with the Illumina Paired-End Sample Prep Kit (cat# PE-102-001; San Diego, CA). Additional file 1: Table S1 summarizes the amount of input DNA used for the individual and pooled exomes along with the sequencing platform and enrichment kit used. The five individual samples and the pooled sample then proceeded through each step of the library preparation protocol as described in the accompanying Agilent protocol.

                      Exome enrichment

                      Exome enrichment from the prepared DNA libraries was performed using the Agilent (Santa Clara, CA) SureSelect Human All Exon Kit [20] for Illumina Paired-End Sequencing Library Prep targeting 38 Mb of the human genome. Hybridization, recovery and enrichment were done according to protocol version 1.0.1, October 2009 with no differences from the stated protocol for the single individual samples. For the pooled sample, two parallel hybridizations were performed and then combined prior to magnetic bead purification in order to optimize the amount of uniformly hybridized sample available for downstream reactions.

                      Individual and pooled exome analysis

                      Raw sequence data in fastq format was aligned to the NCBI human genome build 36 (hg18) [28] using a purchased, multi-threading version of Novoalign [29]. Variant calling from the aligned output for the individual exomes was then performed using SAMtools [23] to manipulate alignments in SAM format and call substitutions as well as insertions and deletions (INDELs).

                      Raw sequence data in fastq format was aligned with Novoalign version 2.05. An alignment threshold of 200 was used (−t 200), with adapter stripping (−a AGATCGGAAGAGCG) and quality calibration enabled (−k). Reads with multiple alignments were discarded (−r none, –e 1) and output was in SAM format (−o SAM). Header lines were removed and the aligned data was then converted to BAM format with SAMtools “import” and sorted with SAMtools “sort”. Duplicate reads were then removed using Picard “MarkDuplicates”. The resulting file was sorted again and indexed with SAMtools “index”. Variants were called with the SAMtools version 0.1.18 mpileup command, using options -AB –ugf and bcftools “view” with settings -bvcg. Variants were filtered with vcfutils “varFilter” using default settings except retaining all variants with under 99999 reads.

                      For the pooled exome sample, the alignment was performed using Novoalign using a reference sequence for the 165,637 bait intervals from the exome capture plus 76 bp flanking bases. The alignment settings are as described above with the exception of output “Native” format instead of SAM format, and the aligned data was converted to a format consistent with the SPLINTER aligner output for SNV calling [30]. These modified files were used as input for variant calling using SPLINTER [9]. To minimize memory limitations during the variant calling process the human genome reference sequence was divided into 166 files with ~1,000 capture baits per file, each file was run as a separate job and parallelized one job per available CPU core. The settings for SNV variant calling using SPLINTER6r were as follows: 24 cycles incorporated, -1.3 p-value cutoff (log10 scale), using only unique reads, 2 edits (mismatches from reference) allowed, specifying a maximum of 10 alleles in the pool. Our prior reports on pooled sequencing relied on internal controls to model sequencing errors and establish a P-value that could be used to calibrate SPLINTER’s sensitivity and specificity for variant calling. The number of sequencing cycles to be incorporated was chosen as described by Vallania [9] based upon error rates identified in 392 base pairs in the FABP1 gene (exon 3 plus 76 bp flanking sequence) with no called variants on the arrays or sequencing (Additional file 1: Figure S1). The model created from this negative control is used by SPLINTER to optimize specificity by subtracting systematic artifacts.

                      Pooled sequencing and indexed custom library preparation

                      The entire protocol is detailed in the Supplemental Methods. The number of individuals multiplexed in each capture reaction and the multiple captures combined for sequencing within one lane of the Illumina HiSeq 2000 platform are detailed in Additional file 1: Table S1. Customized adapter, blocker, pre- and post-hybridization PCR amplification primers and all index sequences used are listed in Additional file 1: Table 5. Briefly, individual DNA samples were collected following informed consent by the Long Life Family Study (LLFS) [31]. For custom hybridization capture of 464 candidate genes thought to be relevant for extreme longevity (Additional file 1: Table 4), a bait set was created using the Agilent eArray online tool [32] for the Agilent SureSelect Custom DNA Capture [20] using 2X tiling frequency, a exon-centered layout strategy, and eliminating probes that overlap standard repeat masked regions by 20 or more bases. Of the 6,630 targeted intervals, 6,369 were covered by at least one bait. These intervals were used for calling variants, as sequence in these intervals without baits due to overlapping standard repeat masked regions could achieve coverage due to adjacent baits. There were 2,500,709 bases (2.5 Mb) covered by baits in 6,966 distinct intervals, and these bases were used when calculating coverage metrics.

                      Pooled sequencing data analysis of 92 individuals at 464 genes

                      For pooled analysis, all reads from the indexed data set using captures of 22–24 individuals (Additional file 1: Table S1, rows 7–10) were considered, and the 7 bp indexes were trimmed from the end of read 1. All analysis was done using the SPLINTER6t package [33]. Forward and reverse reads of each pair were trimmed to 80 bp and analyzed as single reads. Each set of reads (forward and reverse) was compressed with “RAPGAP_read_compressor_v2.pl”. A reference sequence was created in fasta format consisting of the bait-covered intervals with 101 bp flanking regions joined with the PhiX174 reference sequence [34]. The compressed files were aligned with “RAPGAPHASH5d” to this reference sequence allowing up to five mismatches. Each aligned file was tagged with a file-specific identifier using “RAPGAP_alignment_tagger.pl” and the aligned files were concatenated together. An error model was then generated with “EMGENERATOR4” using the entire PhiX174 reference sequence, considering only unique reads, allowing up to five mismatches, and adding pseudocounts. The number of sequencing cycles to be incorporated was chosen as described by Vallania [9], with newer versions of SPLINTER allowing selective discarding of sequencing cycles with high cumulative error rates. The error model of the PhiX174 reads (Additional file 1: Figure S1) shows that cycles 3, 16, 20, 26, 39, 45, 47, 48, 49, 56, 57, 60, and 65 had cumulative error rates >0.02% in one of the two aligned files and were thus eliminated from variant calling. For variant calling with SPLINTER6t, the remaining 67 cycles were considered, up to five mismatches were allowed, the second order error model created with PhiX174 was utilized, a p-value cutoff of −1.3 (log10 scale) was used, and the allele count was set at 200. Coverage mode output was specified to allow coverage of all bases to be considered regardless of the presence of a variant.

                      Of the 92 individuals included in this data, 89 were successfully genotyped by the Illumina Human Omni 2.5-8 Beadchip SNV array. We restricted our comparison between the sequencing and the array by discarding array-based SNV positions as follows: 1) all alleles from the 89 successfully genotyped individuals (n = 178) did not contain a clear call, 2) if the position did not achieve an average of 20-fold coverage per allele in the sequencing data, 3) if the Illumina genotyping output was ambiguous as to the reference and variant allele, 4) if the position was a duplicate within the chip, in which case only one of the duplicate positions was considered. Of the 4,466 positions that overlapped between the array and our sequencing targets, 875 pass these filtering criteria. Of these, 376 were called wild type/wild type by the array in all individuals with no minor allele call by SPLINTER. The remaining 499 SNV positions (45,908 total) had at least one minor allele called by either the array or SPLINTER and were used to determine sequencing SNV concordance against the array.

                      For the 1 bp INDEL analysis, we compared the SPLINTER calls to an aggregate of the individual INDEL calls from the indexed analysis. We again restricted our comparisons to sites with at least 20-fold average coverage per allele, and additionally we considered only sites that were called as INDELs in the individual analysis.

                      Pooled indexed custom capture data analysis

                      Sequencing analysis for indexed captures: Reads are separated by index, allowing for 1 bp mismatches. Reads are then aligned to the human genome (hg19/NCBI 37.0) with Novoalign (V2.07.15) using the parameters “-r none -e 1 -o softclip -H -k -t 200 -i PE 280 100 -a AGATCGGAAGAGCACAC GTCTGAACTCCAGTCACAGATCGGAAGAGCGTCGTGTAGGGAAAGATGTA” and output in SAM format with appropriate read group, ID, sample, platform, and library tags to conform to SAM specifications. Aligned files in SAM format are converted to compressed BAM format with SAMtools “view -bSu” and piped into samtools “sort”. All SAMtools commands were done with samtools-0.1.18. Duplicate reads are removed with picard-tools-1.58 “MarkDuplicates” using default settings and the resulting bam file is indexed by SAMtools. Reads are realigned around candidate INDELs with the Genome Analysis Toolkit’s (version 1.3-21) “RealignerTargetCreator” and “INDELRealigner” using default settings other than restricting the realignment to sequence within 1000 bp of our targeted intervals. Read pair information is fixed with picard-tools-1.58 “FixMateInformation”. This aligned file is indexed with SAMtools to yield the processed aligned file.

                      Variants are called using samtools-0.1.18 mpileup. We specify “-q 5 -Q15 -ABug”, as well as our targeted intervals with 50 bp flanking regions, and pipe the output into bcftools “view -bvcg”. This intermediate file is run through bcftools “view -e” and vcfutils “varFilter -D 1000”. We then change any heterozygous calls with under 20% of the reads matching the reference or variant allele to a homozygous variant genotype or homozygous wild type genotype, respectively.

                      We use the Novoalign metrics output to determine the number of reads that align and we use the Picard “MarkDuplicates” output to determine the percent duplication in our samples. We use the Genome Analysis Tookit’s version 1.0.2885 “DepthOfCoverage” to determine average coverage over specified intervals and utilize the histogram output to calculate the percent of bases reaching various coverage thresholds. We use picard-tools-1.58 “CalculateHSMetrics” to determine the percent of bases directly on our targeted intervals (on target), the percent of bases on and within 250 bp of our targeted intervals (on or near target), the fold enrichment for our captures, and the average coverage achieved by our captures. We specify for our target interval file and our base interval file a list of targets that were directly covered by baits.

                      Comparison of sequencing calls to array calls: The filtering criteria for choosing positions was identical to the pooled analysis, with two exceptions: 1) if an INDEL was called within 15 bp of an array position in at least one individual, that position was discarded, 2) no default coverage threshold was considered. In addition, if a SNV was called within 15 bp of an array position, that position was not considered for that individual. For the multiplexes of 22–24 individuals, 89 of 92 individuals had successful genotyping. For the multiplexes of 48 individuals, 94 of 96 individuals had successful genotyping. For the multiplexes of 30–32 individuals, all 92 individuals had successful genotyping. For each data set, we consider positions with 9 variant alleles or fewer as seen by the array to be rare variants. To calculate sensitivity, we sum the number of positions called heterozygous by the array and heterozygous by sequencing with the number of positions called homozygous variant by the array and homozygous variant by sequencing. We then divide this sum by the total number of positions called heterozygous or homozygous variant by the array. Thus, our sensitivity calculations are predicated on calling genotypes accurately, not solely determining the presence of a variant (i.e. if we call a site heterozygous and the array indicates it is homozygous variant, this counts against our sensitivity). To calculate specificity, we divide the number of positions called homozygous wild type by the array and homozygous wild type by sequencing by the total number of positions called homozygous wild type by the array.

                      Sequencing

                      Sequencing was performed in the Center for Genome Sciences and Systems Biology at Washington University using either the Illumina Genome Analyzer IIx and generating 76 bp paired-end reads or the HiSeq 2000 platform generating 101 bp paired-end reads (Additional file 1: Table S1). Raw sequence data for the exome sequencing is available in dbGaP using accession number phs000553.v1.p1. GWA and sequencing information from the 280 LLFS patients is available in dbGaP using accession number phs000397.v1.p1.

                      Genome wide microarray

                      Individuals undergoing exome sequencing were genotyped by the Affymetrix Genome-wide Human SNV Array 6.0 performed by the Washington University Clinical and Molecular Cytogenetics Laboratory. These data are accessible at dbGaP accession number phs000553.v1.p1. Individuals included in the custom pooled and indexed hybridization capture experiments were genotyped by the Illumina HumanOmni 2.5-8 Beadchip SNV array by the John’s Hopkin’s Center for Inherited Disease Research (CIDR). These data are accessible at dbGaP accession number phs000397.v1.p1.

                      Authors’ information

                      Enrique Ramos and Benjamin T. Levinson regarded as joint First Authors.

                      Abbreviations

                      MAF: 

                      Minor allele frequency

                      SNV: 

                      Single nucleotide variant

                      INDEL: 

                      Insertion or deletion

                      SPLINTER: 

                      Short INDEL Prediction by Large deviation Inference and Non-linear True frequency Estimation by Recursion

                      SPRI: 

                      Solid phase reversible immobilization

                      LLFS: 

                      Long Life Family Study

                      GWA: 

                      Genome wide array.

                      Declarations

                      Acknowledgements

                      This work was supported by the National Institute of Aging [2U01AG023746 to M.P.], National Cancer Institute [1K08CA140720-01A1 to T.E.D.], National Human Genome Research Institute [1F31HG006649-01 to E.I.R.], Alex’s Lemonade Stand Foundation “A” Award [to T.E.D.], and the Children’s Discovery Institute grants MC-FR-2010-99, LI-2009-01 [to T.E.D.]. We would like to thank F. Sessions Cole for generously allowing us access to DNA samples for exome sequencing. We would also like to acknowledge the Clinical and Molecular Cytogenetics Laboratory as well as the Human Genetics Genotyping Core for their assistance with the microarray and Sequenom genotyping, respectively. We also thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The Center is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1RR024992 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.

                      Authors’ Affiliations

                      (1)
                      Center for Genome Sciences and Systems Biology, Washington University School of Medicine
                      (2)
                      Department of Internal Medicine, Division of Cardiology, Washington University School of Medicine
                      (3)
                      Department of Pediatrics, Division of Hematology and Oncology, Washington University School of Medicine
                      (4)
                      Center for Genome Sciences and Systems Biology, Washington University School of Medicine

                      References

                      1. Rivas MA, Beaudoin M, Gardet A, Stevens C, Sharma Y, Zhang CK, Boucher G, Ripke S, Ellinghaus D, Burtt N, Fennell T, Kirby A, Latiano A, Goyette P, Green T, Halfvarson J, Haritunians T, Korn JM, Kuruvilla F, Lagace C, Neale B, Lo KS, Schumm P, Torkvist L, Dubinsky MC, Brant SR, Silverberg MS, National Institute of Diabetes and Digestive Kidney Diseases Inflammatory Bowel Disease Genetics Consortium (NIDDK IBDGC) United Kingdom Inflammatory Bowel Disease Genetics Consortium, International Inflammatory Bowel Disease Genetics Consortium, et al.: Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011, 43:1066–1073.PubMedView Article
                      2. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH: Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004, 305:869–872.PubMedView Article
                      3. Ahituv N, Kavaslar N, Schackwitz W, Ustaszewska A, Martin J, Hebert S, Doelle H, Ersoy B, Kryukov G, Schmidt S, et al.: Medical sequencing at the extremes of body mass. Am J Hum Genet 2007, 80:779–791.PubMedView Article
                      4. Li Y, Vinckenbosch N, Tian G, Huerta-Sanchez E, Jiang T, Jiang H, Albrechtsen A, Andersen G, Cao H, Korneliussen T, et al.: Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet 2010, 42:969–972.PubMedView Article
                      5. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, Shendure J, Bamshad MJ: Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet 2010, 42:30–35.PubMedView Article
                      6. Bilvugar K, Ozturk AK, Louvi A, Kwan KY, Choi M, Tatli B, Yalnizoglu D, Tuysuz B, Caglayan AO, Gokben S, et al.: Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations. Nature 2010, 467:207–210.View Article
                      7. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, Beck AE, Tabor HK, Cooper GM, Mefford HC, et al.: Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010, 42:790–793.PubMedView Article
                      8. Druley TE, Vallania FL, Wegner DJ, Varley KE, Knowles OL, Bonds JA, Robison SW, Doniger SW, Hamvas A, Cole FS, Fay JC, Mitra RD: Quantification of rare allelic variants from pooled genomic DNA. Nat Methods 2009, 6:263–265.PubMedView Article
                      9. Vallania FL, Druley TE, Ramos E, Wang J, Borecki I, Province M, Mitra RD: High-throughput discovery of rare insertions and deletions in large cohorts. Genome Res 2010, 20:1711–1718. available at http://​www.​ibridgenetwork.​org/​wustl/​splinter.PubMedView Article
                      10. Day-Williams AG, McLay K, Drury E, Edkins S, Coffey AJ, Palotie A, Zeggini E: An evaluation of different target enrichment methods in pooled sequencing designs for complex disease association studies. PLoS One 2011, 6:e26279.PubMedView Article
                      11. Harakalova M, Nijman IJ, Medic J, Mokry M, Renkens I, Blankensteijn JD, Kloosterman W, Baas AF, Cuppen E: Genomic DNA pooling strategy for next-generation sequencing-based rare variant discovery in abdominal aortic aneurysm regions of interest – challenges and limitations. J Cardiovasc Trans Res 2011, 4:271–280.View Article
                      12. Cummings N, King R, Rickers A, Kaspi A, Lunke S, Haviv I, Jowett JBM: Combining target enrichment with barcode multiplexing for high throughput SNP discovery. BMC Genomics 2010, 11:641.PubMedView Article
                      13. Kenny EM, Cormican P, Gilks WP, Gates AS, O’Dushlaine CT, Pinto C, Corvin AP, Gill M, Morris DW: Multiplex target enrichment using DNA indexing for ultra-high throughput SNP detection. DNA Res 2011, 18:31–38.PubMedView Article
                      14. Wesolowska A, Dalgaard MD, Borst L, Gautier L, Bak M, Weinhold N, Nielsen BF, Helt LR, Audouze K, Nersting J, et al.: Cost-effective multiplexing before capture allows screening of 25,000 clinically relevant SNPs in childhood acute lymphoblastic leukemia. Leukemia 2011, 25:1001–1006.PubMedView Article
                      15. Nijman IJ, Mokry M, van Boxtel R, Toonen P, de Bruijn E, Cuppen E: Mutation discovery by targeted genomic enrichment of multiplexed barcoded samples. Nat Methods 2010, 7:913–915.PubMedView Article
                      16. Rohland N, Reich D: Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture. Gen Research 2012, 22:939–946.View Article
                      17. Harakalova M, Mokry M, Hrdlickova B, Renkens I, Duran K, van Roekel H, Lansu N, van Roosmalen M, de Bruijn E, Nijman IJ, et al.: Multiplexed array-based and in-solution genomic enrichment for flexible and cost-effective targeted next-generation sequencing. Nat Protocols 2011, 6:1870–1886.View Article
                      18. Bansal V, Tewhey R, Leproust EM, Schork NJ: Efficient and cost effective population resequencing by pooling and in-solution hybridization. PLoS One 2011, 6:e18353.PubMedView Article
                      19. Fisher S, Barry A, Abreu J, Minie B, Nolan J, Delorey TM, Young G, Fennell TJ, Allen A, Ambrogio L, Berlin AM, Blumenstiel B, Cibulskis K, Friedrich D, Johnson R, Juhn F, Reilly B, Shammas R, Stalker J, Sykes SM, Thompson J, Walsh J, Zimmer A, Zwirko Z, Gabriel S, Nicol R, Nusbaum C: A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol 2011, 12:R1.PubMedView Article
                      20. Agilent SureSelect Target Enrichment. http://​www.​genomics.​agilent.​com.
                      21. MAQ: Mapping and Assembly with Quality. http://​maq.​sourceforge.​net.
                      22. Cross_match. http://​www.​phrap.​org.
                      23. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R: The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009, 25:2078–2079. http://​samtools.​sourceforge.​net.PubMedView Article
                      24. Sequenom MassArray. http://​hg.​wustl.​edu/​info/​Sequenom_​description.​html.
                      25. NHGRI’s Exome Variant Server, Support Vector Machine. http://​evs.​gs.​washington.​edu/​EVS/​; using February 2012 data.
                      26. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, McKenna A, Fennell TJ, Kernytsky AM, Sivachenko AY, Cibulskis K, Gabriel SB, Altshuler D, Daly MJ: A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011, 43:491–498.PubMedView Article
                      27. Kircher M, Sawyer S, Meyer M: Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform. Nucleic Acids Res 2012, 40:e3.PubMedView Article
                      28. NCBI Human Genome Reference Sequence, Build 36 (hg18). http://​www.​ncbi.​nlm.​nih.​gov/​mapview/​stats/​BuildStats.​cgi?​taxid=​9606&​build=​36&​ver=​3.
                      29. Novoalign, license purchased from Novocraft Technologies. http://​www.​novocraft.​com.
                      30. Druley lab, script for converting Novoalign output to SPLINTER variant calling format. http://​druleylab.​wustl.​edu/​ under the “Projects: Pooled hybridization capture with indexing” tab.
                      31. Long Life Family Study. http://​www.​longlifefamilyst​udy.​org/​.
                      32. Agilent eArray hybridization capture bait design tool. https://​earray.​chem.​agilent.​com/​earray/​.
                      33. SPLINTER6t bioinformatics package update. available at http://​www.​genetics.​wustl.​edu/​rmlab. available at .
                      34. PhiX174 reference sequence. http://​www.​ncbi.​nlm.​nih.​gov/​nuccore/​9626372?​report=​fasta.

                      Copyright

                      © Ramos et al.; licensee BioMed Central Ltd. 2012

                      This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.